openPR Logo
Press release

Peripheral Artery Disease Market to Witness Upsurge in Growth During the Forecast Period | Ixaka Ltd, Hemostemix, Caladrius Biosciences, Humacyte

04-25-2024 02:22 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Peripheral Artery Disease Market

Peripheral Artery Disease Market

DelveInsight's "Peripheral Artery Disease Market Insights, Epidemiology and Market Forecast- 2032" report delivers an in-depth understanding of the Peripheral Artery Disease, historical and forecasted epidemiology as well as the Peripheral Artery Disease market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
According to DelveInsight's analysis, the Peripheral Artery Disease (PAD) market is projected to experience significant growth in the foreseeable future. This trajectory is attributed to the increasing prevalence of PAD across the 7 major markets (7MM), ongoing Research and Development (R&D) endeavors, the active involvement of leading pharmaceutical and biotechnology companies in this therapeutic area, and the anticipated introduction of emerging therapies.

In 2022, the market size of Peripheral Artery Disease was highest in the US among the 7MM accounting for approximately USD 4 billion, and lowest in Spain with USD 130 million which is further expected to increase by 2032.

The developing pipeline for Peripheral Artery Disease predominantly consists of cell therapies. Notable among these are Ixaka's REX-001, Hemostemix's ACP-01, Humacyte's Human Acellular Vessel (HAV), and Caladrius Bioscience's Honedra. These emerging therapies span various stages of development, including late-stage, mid-stage, and early-stage. Several of these promising treatments are poised to make their market debut in the near term.

DelveInsight's "Peripheral Artery Disease Market Insights, Epidemiology, and Market Forecast 2032 [https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Peripheral Artery Disease market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Peripheral Artery Disease market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Peripheral Artery Disease Overview

Peripheral artery disease represents a prevalent manifestation of arterial narrowing in the upper and/or lower extremities, resulting in diminished blood flow. It's widely recognized that PAD correlates with heightened morbidity and mortality in cardiovascular (CV) disease. In PAD, typically affecting the legs, insufficient blood supply fails to meet the body's demand, leading to symptoms like leg pain during walking (claudication) and other associated discomforts.

While some individuals with PAD remain asymptomatic, the hallmark indication of lower-extremity PAD often manifests as painful muscle cramps in the hips, thighs, or calves during physical activity like walking, climbing stairs, or exercising. These discomforts, known as intermittent claudication, typically subside with rest. Symptoms of PAD tend to progress gradually over time. However, any sudden onset or exacerbation of symptoms may signal a serious issue necessitating prompt medical intervention.

Peripheral Artery Disease Market Key Facts

*
As per DelveInsight's estimate, in 2021, there were 36,661,000+ cases of PAD in the 7MM. Approximately 55% of cases were reported in the US, compared to about 39% of cases in EU-5; Germany accounted for the highest number among EU-5 countries.

*
According to Alzamora et al. (2016), the occurrence of Peripheral Artery Disease is higher in men, especially < 65 years.

*
As per the assessment, Japan accounted for the lowest number of Peripheral Artery Disease cases among the 7MM.

*
The highest number of cases (approximately 61%) were diagnosed in the US, followed by EU-5 and Japan.

Peripheral Artery Disease Market [https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Peripheral Artery Disease market size [https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Peripheral Artery Disease market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.

Peripheral Artery Disease Epidemiology Assessment

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders.

The Report Covers the Peripheral Artery Disease Epidemiology Segmented by-

*
Total Prevalent Cases of PAD in the 7MM

*
Total Diagnosed Prevalent Cases of PAD in the 7MM

*
Severity-specific Prevalent Cases of PAD in the 7MM

*
Age-specific Prevalent Cases of PAD in the 7MM

*
Gender-specific Cases of PAD in the 7MM

*
Treatable Cases of PAD in the 7MM

Peripheral Artery Disease Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peripheral Artery Disease market or expected to be launched during the study period. The analysis covers the Peripheral Artery Disease market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Peripheral Artery Disease pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Peripheral Artery Disease Market Will Evolve and Grow by 2032 @ https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market [https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Peripheral Artery Disease Therapeutics Analysis

As per DelveInsight's assessment, with the increasing prevalent cases of Peripheral Artery Disease and the expected launch of upcoming therapies, the Peripheral Artery Disease market is anticipated to grow at an immense pace in the coming years.

Key Peripheral Artery Disease companies working in the peripheral artery disease market who are in different phases of developing therapies are - NovoNordisk, Takeda, Mercator MedSystems, Inc., Beijing Northland Biotech. Co., Ltd., Ixaka Ltd, Humacyte, Inc., CardioVascular BioTherapeutics, Proteon Therapeutics, ReNeuron Limited, Alucent Biomedical, Athersys, ARCA biopharma, Ambulero, Venturis Therapeutics and others.

The Leading Companies in the Peripheral Artery Disease Therapeutics Market Include:

*
Merck & Co., Inc

*
Aralez Pharmaceuticals

*
Legacy-Xspire Holdings

*
Janssen Pharmaceutical

*
Reven Pharmaceuticals, Inc.)

*
New Beta Innovation Limited

*
Mercator MedSystems

*
Ixaka Ltd (formerly known as Rexgenero)

*
Hemostemix

*
Caladrius Biosciences

*
Humacyte, Inc.

*
And Many More

Peripheral Artery Disease Therapies Covered in the Report Include:

*
REX-001: Ixaka Ltd (formerly known as Rexgenero)

*
ACP-01: Hemostemix

*
SAKIGAKE designated Honedra (formerly known as CLBS12): Caladrius Biosciences

*
Human Acellular Vessel (HAV): Humacyte, Inc.

*
RJX (Rejuveinix): Reven Pharmaceuticals, Inc.)

*
YQ23: New Beta Innovation Limited

*
Temsirolimus: Mercator MedSystems

*
And Many Others

Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @ https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market [https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Table of Content

1. Key Insights

2. Executive Summary

3. Peripheral Artery Disease Competitive Intelligence Analysis

4. Peripheral Artery Disease Market Overview at a Glance

5. Peripheral Artery Disease Disease Background and Overview

6. Peripheral Artery Disease Patient Journey

7. Peripheral Artery Disease Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Peripheral Artery Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Peripheral Artery Disease Unmet Needs

10. Key Endpoints of Peripheral Artery Disease Treatment

11. Peripheral Artery Disease Marketed Products

12. Peripheral Artery Disease Emerging Drugs and Latest Therapeutic Advances

13. Peripheral Artery Disease Seven Major Market Analysis

14. Attribute Analysis

15. Peripheral Artery Disease Market Outlook (In US, EU5, and Japan)

16. Peripheral Artery Disease Access and Reimbursement Overview

17. KOL Views on the Peripheral Artery Disease Market

18. Peripheral Artery Disease Market Drivers

19. Peripheral Artery Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peripheral-artery-disease-market-to-witness-upsurge-in-growth-during-the-forecast-period-ixaka-ltd-hemostemix-caladrius-biosciences-humacyte]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral Artery Disease Market to Witness Upsurge in Growth During the Forecast Period | Ixaka Ltd, Hemostemix, Caladrius Biosciences, Humacyte here

News-ID: 3475574 • Views:

More Releases from ABNewswire

How Mid State Firearms Redefines Quality in AR-15 Upper Receivers
How Mid State Firearms Redefines Quality in AR-15 Upper Receivers
Discover how Mid State Firearms sets a new standard in AR-15 upper receivers with custom builds, premium materials, and unmatched attention to detail. The AR15 upper is more than just a component; it is the heart of the AR-15 platform. Serving as the foundation for accuracy, durability, and modularity, the upper receiver determines how reliably an AR-15 will perform under real-world conditions. A well-machined AR15 upper receiver ensures proper cycling, enhanced
Excellence Awards Announce 2025 Winners for Pacific USA: Celebrating Leadership and Innovation on the West Coast
Excellence Awards Announce 2025 Winners for Pacific USA: Celebrating Leadership …
The Excellence Awards team is proud to unveil the recipients of the CEO of the Year Awards Pacific USA 2025. These awards honor CEOs who are driving transformation through bold vision, resilience, and innovation - each leaving a distinct mark on one of the most dynamic regions in the United States. Redefining Leadership in the Pacific USA From Silicon Valley to Los Angeles, from Seattle to Portland - this year's honorees embody
Florida Panthers Amerant Bank Arena Tickets on Sale Now - Save with Promo Code CITY10 at CapitalCityTickets.com
Florida Panthers Amerant Bank Arena Tickets on Sale Now - Save with Promo Code C …
Score big savings on Florida Panthers Amerant Bank Arena tickets now available at CapitalCityTickets.com. Use promo code CITY10 at checkout to unlock extra discounts on seats for every home game. Whether you're after premium lower bowl action, club level comfort, or affordable upper bowl views, buying early ensures the best selection and prices. Don't miss your chance to cheer on the Panthers live-secure your discounted tickets today! The Florida Panthers are
QuoteIQ Revolutionizes $7.3 Billion Carpet Cleaning Industry with Cutting-Edge Self-Service Technology
QuoteIQ Revolutionizes $7.3 Billion Carpet Cleaning Industry with Cutting-Edge S …
InstaQuote and InstaSchedule Features Drive Revenue Growth, Reduce No-Shows by 90%, and Position Industry Leaders for Digital Success SAVANNAH, GA - Oct 1, 2025 - QuoteIQ, the rapidly expanding business management software platform, today announced unprecedented growth in the carpet cleaning sector following the successful deployment of its revolutionary self-service quoting and scheduling technology. As the $7.3 billion U.S. carpet cleaning industry struggles with outdated legacy systems, QuoteIQ is filling a

All 5 Releases


More Releases for Peripheral

Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev …
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820 This latest report researches the industry structure,
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a